Back to search

University of British Columbia

The development of ¹⁸F-fluorescent-RBF₃ PET tracers, new radioprosthetic trifluoroborates, and the use of tetrafluoroborate salts for organotrifluoroborate synthesis

Abstract

dc:description

The development of ¹⁸F-¹⁹F isotope exchange (IEX) enables the use of organotrifluoroborates (RBF₃ₛ), namely ammonium methylenetrifluoroborates (AMBF₃), in clinical diagnostic imaging of cancer through ¹⁸F-Positron Emission Tomography (¹⁸F PET). There is an ongoing interest in advancing RBF₃ radioprosthetics to create a dual-mode tracer that integrates a fluorescent component with PET radiotracers. Chapter 2 discloses the development of a fluorescent-RBF₃ tracer that can be used for both PET and fluorescent imaging of cancer. Two distinct fluorescent radiotracers that employ two forms of fluorescein (FAM or FITC) with a modified AMBF₃ on a PSMA-targeting ligand were synthesized. Both tracers demonstrated improved radiochemical properties, tumor uptake, and tumor to non-tumor ratios compared to previous generations of non-fluorescent RBF₃ₛ in the literature. The PSMA-Fluor-RBF₃ tracers afforded exceptional PET images, but there were challenges in visualizing tumors in LNCaP cell lines with fluorescence. Consequently, PET scans and fluorescent images for both radiotracers were obtained on an alternative cell line, 22Rv1. The success of dual-mode imaging of 22Rv1 xenograft cancer models in mice proved that the compounds are viable pre-clinical fluorescent-PET tracers. Chapter 3 discusses the contributions towards the continued development and optimization of AMBF₃ₛ. Two novel RBF₃ prostheses were developed and were subsequently appended onto PSMA617 and LY2510924 peptides. The effects of adding carboxylates to lipophilic PSMA-RBF₃ tracers were also explored, which resulted in increased targeted tumor uptake and lower renal uptake. The first applications of ¹⁸F-RBF₃ PET imaging on thymidine-based ligands were also investigated. Chapter 4 discusses the development of a novel method for synthesizing RBF₃ₛ through a salt metathesis reaction starting with an arylboronic acid in the presence of NaBF₄. In this reaction, MeOBF₃ was noted to be an important intermediate that was generated when mixing MeOH and NaBF₄. The salt metathesis reaction was further optimized, resulting in conditions that provided near-instantaneous conversion of organoboronic acids to RBF₃ₛ. The novel work reported in this thesis represents 1) the development of fluorescent PSMA-RBF₃ₛ for dual-mode imaging; 2) the optimizations on RBF₃ and its effects on radiochemical properties and biodistribution in mice; and 3) the development of a new method for the synthesis of RBF₃ₛ.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Chemistry
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lozada, Jerome
Contributors dc:contributor
  • Perrin, David M.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88723

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lozada, Jerome. The development of ¹⁸F-fluorescent-RBF₃ PET tracers, new radioprosthetic trifluoroborates, and the use of tetrafluoroborate salts for organotrifluoroborate synthesis. doctoral thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88723